Global Money Is Chasing Indian Stocks Again as Bull Run Extends
Overseas funds are piling money into Indian stocks, marking a strong return to the $5 trillion market after election-related ...
India's markets regulator eases credit default swap norms for mutual funds
India's markets regulator has allowed mutual funds to both buy and sell credit default swaps (CDSs) under certain conditions, ...
Brookfield-backed Leela hotels owner Schloss files for $599 mln India IPO
Schloss Bangalore, owner of Indian luxury hotel chain 'The Leela', has filed for a 50 billion rupee ($599 million) IPO on ...
India markets regulator bars Axis Capital from acting as banker for new debt issues
India's markets regulator on Thursday barred investment bank Axis Capital from acting as a merchant banker for new debt ...
Softbank-Backed Swiggy Said to Eye India IPO Filing This Week
Indian food-delivery platform Swiggy Ltd. is considering filing publicly for its domestic initial public offering as soon as ...
One of the cybersecurity risks to securities market may be difficult to eliminate; Deloitte India's Kamdar explains why
In an interview given to Moneycontrol, Munjal Kamdar, with over two decades in the BFSI sector and who is an expert in cyber ...
Shares to buy or sell: Rajesh Palviya of Axis Securities suggests these three stocks to buy, hold and accumulate today
Rajesh Palviya has recommended to buy, hold, and accumulate Oberoi Realty Ltd, Kotak Mahindra Bank Ltd, and Max Healthcare ...
Here’s how authorities ought to deal with India’s market froth
Among other factors, scarce investment avenues other than equity shares and dubious practices amid a stock market boom have ...
Leela Hotels Prepares for $610 Million IPO: India’s Largest IPO in the Hospitality Sector
Leela Palaces, a luxury hotel chain in India, has filed for an IPO to raise Rs 5,000 crore. This marks a significant step for ...
Despite FPIs inflow decline, net selling by DIIs this week, Indian markets post new highs
Foreign Portfolio Investment FPI in India witnessed a significant decline this week amid market volatility driven by concerns over possible interest rate cuts ...
Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer
DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today ...